Some studies have indicated that TGFβ1 can activate TAK1 through the TGFBR1/2 complex, with activated TAK1 promoting cardiac hypertrophy via the p38/MAPK-JNK1/2 signaling pathway [46–48]. Here, MAPK8 is linked to cardiac hypertrophy.